ROC curve analysis exhibited that LEP promoter methylation may be severed as an underlying biological marker for distinguishing AML from controls with an AUC of 0.803 (95% CI 0.747–0.858, P < 0.001, Fig. 2f). This evidence concerns the gene LEP and acute myeloid leukemia.